Indian Institute of Integrative Oncology, a dream concept of Prof.Dr. Sandeep Roy is an organization dedicated to a campaign for cancer awareness, cancer prevention and introduction of a revolutionary treatment for cancer. Indian Institute of Integrative Oncology (IIIO) has introduced the famous “Mistletoe Therapy (viscum album/lecitin)” for the treatment of cancer.

1. WHAT IS MISTLETOE THERAPY?

2. Study
• A new observational study has found that patients with late-stage non-
small cell lung cancer (NSCLC) receiving supplementary mistletoe
treatment in addition to chemotherapy were able to survive significantly
longer than patients receiving chemotherapy alone.
• The 2nd most studied mode of CANCER treatment after the
conventional ones with over 130 clinical trials and about 3000 published
research papers to its credit.
• Patented Oral Formulation of Mistletoe Extracts for Cancer Management
has the highest concentration of lectins, viscotoxins and polysaccharides
for better induction of apoptosis and better immunomodulation.

3. RESEARCH ON MISTLETOE (VISCUM
ALBUM) EXTRACT IN CANCER
● Complementary cancer therapies are widely used all over the world. In Europe, 40% (depending on the country
15-73%) of cancer patients use complementary therapy, mostly herbal remedies.
● Mistletoe (Viscum Album) extracts are most commonly found in German-speaking Central Europe (Viscum album
L., UAE). Even children with cancer often receive Mistletoe (Viscum Album) therapy. Registered doctors in
Germany estimate that mistletoe therapy for cancer treatment.
● The biological and pharmacological effects of Viscum album L. extracts (VAE) have been extensively analyzed.
Various pharmacologically active ingredients have been isolated, for example, Mistletoe (Viscum Album) lectins,
viscotoxins, oligo- and polysaccharides, lipids, and several others. The most striking features of VAE are its
cytotoxic and growth-inhibitory effects on a variety of tumor cell lines, lymphocytes, and fibroblasts in vitro. The
cytotoxic effects of VAE are mainly caused by apoptosis-inducing Mistletoe (Viscum Album) lectins, while
● VAE is also known for its immunomodulating activity. In vitro and in vivo, they activate monocytes/macrophages,
granulocytes, natural killer cells (NK cells), T cells (especially T helper cells), and induce a wide range of cytokines.
● VAE also stabilizes DNA, reduces chromosome damage, and improves DNA repair. In animals, VAE shows marked
antitumoral effects.
● Mistletoe (Viscum Album) lectin I, an important ingredient in Mistletoe (Viscum Album) extracts, is currently also
produced recombinantly and tested for use in clinical oncology.

4. AVAILABILITY
• Mistletoe therapy for cancer treatment is available
nearly in all the continents and countries.
• Diluted forms of mistletoe extract are available in
the United States.

5. ORAL MISTLETOE
Difference between oral and injectable mistletoe Oral Mistletoe :
• We can give high doses orally.
• Oral Mistletoe is approved by the FDA
• Regulatory Oral Mistletoe has been approved by regulatory
authorities of FDA / FSSAI.
• Injectable Mistletoe :
• We can provide only a low dose
• Mistletoe injections are not approved by FDA

6. CURCUMIN AND CANCER
● The main active ingredient in turmeric is curcumin or diferuloylmethane. Laboratory
studies have shown curcumin has anti-cancer effects on cancer cells.
● Curcumin cancer treatment has been evaluated in animal models of different cancer
types. These studies have generally shown that curcumin and radiation therapy has
antiproliferative effects. For example, a mouse model of colorectal cancer (CRC) that was
treated by intraperitoneal injection of curcumin or vehicle control demonstrated that
curcumin prolonged life and inhibited tumor growth.
● This data also suggests that curcumin upregulated the miRNA miR-130a, which decreased
the Wnt/β-catenin pathway and led to prolonged survival.
● It’s both antioxidant-rich and a fantastic daily supplement for promoting a healthy
inflammation response in the body.